TY  - JOUR
AU  - Ampuero, Javier
AU  - Pais, Raluca
AU  - Aller, Rocío
AU  - Gallego-Durán, Rocío
AU  - Crespo, Javier
AU  - García-Monzón, Carmelo
AU  - Boursier, Jerome
AU  - Vilar, Eduardo
AU  - Petta, Salvatore
AU  - Zheng, Ming-Hua
AU  - Escudero, Desamparados
AU  - Calleja, Jose Luis
AU  - Aspichueta, Patricia
AU  - Diago, Moisés
AU  - Rosales, Jose Miguel
AU  - Caballería, Joan
AU  - Gómez-Camarero, Judith
AU  - Lo Iacono, Oreste
AU  - Benlloch, Salvador
AU  - Albillos, Agustín
AU  - Turnes, Juan
AU  - Banales, Jesus M
AU  - Ratziu, Vlad
AU  - Romero-Gómez, Manuel
AU  - HEPAmet Registry
PY  - 2019
DO  - 10.1016/j.cgh.2019.05.051
UR  - http://hdl.handle.net/10668/14108
T2  - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
AB  - Fibrosis affects prognoses for patients with nonalcoholic fatty liver disease (NAFLD). Several non-invasive scoring systems have aimed to identify patients at risk for advanced fibrosis, but inconclusive results and variations in features of patients...
LA  - en
KW  - Cirrhosis
KW  - Diagnostic Tool
KW  - HOMA
KW  - Prognostic Factor
KW  - Steatosis
KW  - Adult
KW  - Aged
KW  - Biopsy
KW  - Cross-Sectional Studies
KW  - Decision Support Techniques
KW  - Female
KW  - Humans
KW  - Liver
KW  - Liver Cirrhosis
KW  - Male
KW  - Middle Aged
KW  - Non-alcoholic Fatty Liver Disease
KW  - Prognosis
KW  - Severity of Illness Index
TI  - Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
TY  - research article
VL  - 18
ER  -